BNGOBionano Genomics, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · bionano.com

1.200USD-2.44%Mkt Cap: 14.13M $P/E: —3d ago

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap14.13M $

Enterprise Value11.04M $

Revenue (TTM)30.18M $

Gross Profit13.19M $

Net Income (TTM)-26.39M $

Revenue/Share3.162 USD

Last Price1.200 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees95

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.25

PEG—

EV/EBITDA-0.48

EV/Revenue0.37

P/S0.47

P/B0.45

EPS (TTM)-2.97

EPS (Forward)-0.97

52W Range

1.0004% of range5.500

52W High5.500 USD

52W Low1.000 USD

Profitability

Gross Margin46.25%

Oper. Margin-88.34%

EBITDA Margin-75.80%

Profit Margin-92.59%

ROE-59.42%

ROA-35.87%

Growth

Revenue Growth21.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-16.34M $

CapEx (TTM)—

FCF Margin7.78%

FCF Yield16.61%

Net Debt-3.21M $

Net Debt/EBITDA0.14

Balance Sheet

Debt/Equity0.16

Current Ratio2.48

Quick Ratio1.42

Book Value/Sh2.684 USD

Cash/Share0.8420 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:60

Split DateJan 27, 2025

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)5.000 USD

Upside (mean)+316.7%

Target Range4.000 USD – 6.000 USD

$4.000+316.7% to mean$6.000

# Analysts2

Ownership

Shares Out.11.78M

Float10.64M

Insiders7.22%

Institutions8.49%

Short Interest

Short Ratio9.1d

Short % Float9.29%

Short % Out.9.29%

Shares Short1.07M

Short (prev mo.)1.16M

Technical

SMA 501.146 (+4.7%)

SMA 2001.301 (-7.8%)

Beta1.62

S&P 52W Chg18.16%

Avg Vol (30d)120.75K

Avg Vol (10d)144.42K

Technical Indicators

RSI (14)57.5

MACD0.0169

MACD Signal0.0049

MACD Hist.+0.0120

BB Upper1.241 USD

BB Middle1.136 USD

BB Lower1.032 USD

BB Width18.42%

ATR (14)0.0525 USD

Vol Ratio (20d)1.43x